alcam Search Results


93
R&D Systems alcam cd166
Alcam Cd166, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/alcam/Human+ALCAM%2FCD166+Antibody/pm38426282-295-31-32
Average 93 stars, based on 1 article reviews
alcam cd166 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

90
R&D Systems recombinant human alcam fc chimera
Elevated hepatic and serum <t>ALCAM</t> were observed in patients with AIH. (A) Representative immunohistochemistry images of ALCAM in liver biopsies from HC (n=3) and patients with AIH (n=6). (B) Representative immunofluorescence staining for CD4, CD6 and ALCAM in interface hepatitis lesion of liver sections from patients with AIH (n=3). (C) Concentration of serum ALCAM in HC (n=28) and AIH (n=86) was measured by ELISA assay. Individual correlation between clinical indicators and serum ALCAM was calculated in patients with AIH (n=86). (D) Correlation between the number of hepatic CD6 + cells and paired serum ALCAM concentration was calculated (n=27). ***p < 0.001.
Recombinant Human Alcam Fc Chimera, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/alcam/Recombinant+Human+ALCAM+Fc+Chimera+(HEK293-expressed)%2C+CF/pmc09500242-77-0-5
Average 90 stars, based on 1 article reviews
recombinant human alcam fc chimera - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

92
R&D Systems af1172
Elevated hepatic and serum <t>ALCAM</t> were observed in patients with AIH. (A) Representative immunohistochemistry images of ALCAM in liver biopsies from HC (n=3) and patients with AIH (n=6). (B) Representative immunofluorescence staining for CD4, CD6 and ALCAM in interface hepatitis lesion of liver sections from patients with AIH (n=3). (C) Concentration of serum ALCAM in HC (n=28) and AIH (n=86) was measured by ELISA assay. Individual correlation between clinical indicators and serum ALCAM was calculated in patients with AIH (n=86). (D) Correlation between the number of hepatic CD6 + cells and paired serum ALCAM concentration was calculated (n=27). ***p < 0.001.
Af1172, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/alcam/Human%2FMouse%2FRat%2FCanine+ALCAM%2FCD166+Antibody/pmc08217895__sj___pdf___1___jcb___10__1177_0271678X20968943-12-0-1
Average 92 stars, based on 1 article reviews
af1172 - by Bioz Stars, 2026-10
92/100 stars
  Buy from Supplier

94
Proteintech alcam
Elevated hepatic and serum <t>ALCAM</t> were observed in patients with AIH. (A) Representative immunohistochemistry images of ALCAM in liver biopsies from HC (n=3) and patients with AIH (n=6). (B) Representative immunofluorescence staining for CD4, CD6 and ALCAM in interface hepatitis lesion of liver sections from patients with AIH (n=3). (C) Concentration of serum ALCAM in HC (n=28) and AIH (n=86) was measured by ELISA assay. Individual correlation between clinical indicators and serum ALCAM was calculated in patients with AIH (n=86). (D) Correlation between the number of hepatic CD6 + cells and paired serum ALCAM concentration was calculated (n=27). ***p < 0.001.
Alcam, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/alcam/ALCAM+Antibody/pm40131296-73-18-19
Average 94 stars, based on 1 article reviews
alcam - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

93
R&D Systems clone 105902
Elevated hepatic and serum <t>ALCAM</t> were observed in patients with AIH. (A) Representative immunohistochemistry images of ALCAM in liver biopsies from HC (n=3) and patients with AIH (n=6). (B) Representative immunofluorescence staining for CD4, CD6 and ALCAM in interface hepatitis lesion of liver sections from patients with AIH (n=3). (C) Concentration of serum ALCAM in HC (n=28) and AIH (n=86) was measured by ELISA assay. Individual correlation between clinical indicators and serum ALCAM was calculated in patients with AIH (n=86). (D) Correlation between the number of hepatic CD6 + cells and paired serum ALCAM concentration was calculated (n=27). ***p < 0.001.
Clone 105902, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/alcam/Human+ALCAM%2FCD166+PE-conjugated+Antibody/pm39740663-702-171-173
Average 93 stars, based on 1 article reviews
clone 105902 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

92
Santa Cruz Biotechnology anti mouse cd166
Comparative analysis of MSC and Chondrocyte markers in the tissue (D0) isolated from mild and severe OA regions. ( A ) The mRNA expression levels of CD105, <t>CD166</t> and Notch 1 (MSC markers) in mild versus severe OA at D0; ( B ) The mRNA expression levels of Sox9, Acan and Col II (chondrocyte markers) in mild versus severe OA at D0. Mild OA is used as the control expression to normalized results.
Anti Mouse Cd166, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/alcam/ALCAM+Antibody/pmc05578148-122-52-56
Average 92 stars, based on 1 article reviews
anti mouse cd166 - by Bioz Stars, 2026-10
92/100 stars
  Buy from Supplier

90
R&D Systems cd166 fitc
( a ) Representative FACS profiles of stromal cells (CD45 − Ter119 − CD31 − ) near the endosteum (bone-disassociated). They were separated based on their <t>CD166,</t> CD146 and Sca1 expression profiles. Numbers shown in the gate represent the percentage of total live cells. ( b ) Single-cell colony forming efficiency of BM stromal progenitors (*: P ≤0.05, three repeats of 60 cells each, student's t -test). ( c ) Sections of femur from Flk1-GFP mouse stained with antibodies against Sca1 and scanned with an iCys Research imaging cytometer. Nuclei were stained with Dapi. ( d ) Confocal maximum intensity projections of sections of femurs from Flk1-GFP mice stained with antibodies against Sca1 or CD146; scanned near the epiphyseal plate. ( e ) Confocal maximum intensity projections of sections of femur stained with antibodies against Sca1 or CD146 and laminin; scanned near epiphyseal plate. White arrows point to mesenchymal progenitors yellow arrows point to endothelial cells.
Cd166 Fitc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/alcam/Mouse+ALCAM%2FCD166+Fluorescein-conjugated+Antibody/pmc05062560-221-25-27
Average 90 stars, based on 1 article reviews
cd166 fitc - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

93
R&D Systems alcam
Comparison of urine biomarkers among patients with SLE, LN, and healthy controls. (A) Urine level of <t>ALCAM.</t> (B) Urine level <t>of</t> <t>HPX.</t> (C) Urine level of PRDX6. Statistical analyses were conducted using the Mann–Whitney U test. SLE, systemic lupus erythematosus; LN, lupus nephritis; ALCAM, activated leukocyte cell adhesion molecule; HPX, hemopexin; PRDX, peroxiredoxin.
Alcam, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/alcam/Human+ALCAM+DuoSet+ELISA/pmc11194348-105-18-22
Average 93 stars, based on 1 article reviews
alcam - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

90
R&D Systems cd166 alcam elisa kit
Comparison of urine biomarkers among patients with SLE, LN, and healthy controls. (A) Urine level of <t>ALCAM.</t> (B) Urine level <t>of</t> <t>HPX.</t> (C) Urine level of PRDX6. Statistical analyses were conducted using the Mann–Whitney U test. SLE, systemic lupus erythematosus; LN, lupus nephritis; ALCAM, activated leukocyte cell adhesion molecule; HPX, hemopexin; PRDX, peroxiredoxin.
Cd166 Alcam Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/alcam/Human+ALCAM%2FCD166+ELISA+Kit+(Chemiluminescence)/pm23319340-95-19-23
Average 90 stars, based on 1 article reviews
cd166 alcam elisa kit - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

93
R&D Systems goat anti human alcam
Coronal cryostat sections of the hindbrain of E11 and E13 embryos and spinal cord (brachial level) of E11 embryos . a-b , In Foxg1:Cre;Netrin-1 L/+ embryos as in wild type, netrin-1 is in the hindbrain VZ (arrowhead) and commissural axons (arrow). This is not the case in Foxg1:Cre;Netrin-1 L/L mutant. The floor plate is still labelled (Fp). Note that netrin-1 is present in the vicinity of the Fp (n=6). c , Foxg1:Cre drives Cre expression in E13 (left) and E11 (right) hindbrain cells (Tomato+ cells in red) but not in the floor plate (arrowheads; n=3/3). A few <t>Alcam+</t> floor plate cells are Tomato+. d, e, Netrin-1 distribution is similar in the spinal cord of Foxg1:Cre;Netrin-1 L/+ (d) and Foxg1:Cre;Netrin-1 L/L ( e ) embryos (n=5). f , In Netrin1 ßgeo/ßgeo , Foxp2+ olivary neurons fail to migrate (arrowheads) ventrally and only few of them are able to reach to the floor plate (arrowheads; n=6). g , Quantification of the size of hindbrain commissures in the different mutants compared to controls. Six embryos of each genotype and 9 sections from each were quantified. Data are normalized with the wt and are represented as the mean ± SEM (One-way Kruskal-Wallis with Mann-Whitney post-test, *P<0.05, ns, not significant). h, Netrin-1 guidance mechanisms of hindbrain commissural axons: past and current models. In the initial model, soluble netrin-1 secreted by floor plate (FP) forms a ventro-dorsal gradient, which attracts ventrally commissural axon (CN) growth cones (GC). In the revised model, pioneer CN axons form in a superficial region containing high levels of netrin-1 produced by neural progenitor cells (NPCs) extending from the ventricular zone (VZ) to the basal lamina (BL) at the surface of the hindbrain. CN axons might also capture Netrin-1 and establish a netrin-1-rich pathway guiding follower axons. Their ventral extension might be facilitated by chemorepellents (question mark) produced in the dorsal hindbrain. Scale bars, 100µm.
Goat Anti Human Alcam, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/alcam/Human+ALCAM%2FCD166+Antibody/pmc05438598-40-68-72
Average 93 stars, based on 1 article reviews
goat anti human alcam - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

94
Miltenyi Biotec cd45 fluorescein isothiocyanate fitc
Coronal cryostat sections of the hindbrain of E11 and E13 embryos and spinal cord (brachial level) of E11 embryos . a-b , In Foxg1:Cre;Netrin-1 L/+ embryos as in wild type, netrin-1 is in the hindbrain VZ (arrowhead) and commissural axons (arrow). This is not the case in Foxg1:Cre;Netrin-1 L/L mutant. The floor plate is still labelled (Fp). Note that netrin-1 is present in the vicinity of the Fp (n=6). c , Foxg1:Cre drives Cre expression in E13 (left) and E11 (right) hindbrain cells (Tomato+ cells in red) but not in the floor plate (arrowheads; n=3/3). A few <t>Alcam+</t> floor plate cells are Tomato+. d, e, Netrin-1 distribution is similar in the spinal cord of Foxg1:Cre;Netrin-1 L/+ (d) and Foxg1:Cre;Netrin-1 L/L ( e ) embryos (n=5). f , In Netrin1 ßgeo/ßgeo , Foxp2+ olivary neurons fail to migrate (arrowheads) ventrally and only few of them are able to reach to the floor plate (arrowheads; n=6). g , Quantification of the size of hindbrain commissures in the different mutants compared to controls. Six embryos of each genotype and 9 sections from each were quantified. Data are normalized with the wt and are represented as the mean ± SEM (One-way Kruskal-Wallis with Mann-Whitney post-test, *P<0.05, ns, not significant). h, Netrin-1 guidance mechanisms of hindbrain commissural axons: past and current models. In the initial model, soluble netrin-1 secreted by floor plate (FP) forms a ventro-dorsal gradient, which attracts ventrally commissural axon (CN) growth cones (GC). In the revised model, pioneer CN axons form in a superficial region containing high levels of netrin-1 produced by neural progenitor cells (NPCs) extending from the ventricular zone (VZ) to the basal lamina (BL) at the surface of the hindbrain. CN axons might also capture Netrin-1 and establish a netrin-1-rich pathway guiding follower axons. Their ventral extension might be facilitated by chemorepellents (question mark) produced in the dorsal hindbrain. Scale bars, 100µm.
Cd45 Fluorescein Isothiocyanate Fitc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/alcam/CD166+Antibody%2C+anti-human%2C+REAfinity/10__36922_slash_or026140021-66-28-32
Average 94 stars, based on 1 article reviews
cd45 fluorescein isothiocyanate fitc - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

Image Search Results


Elevated hepatic and serum ALCAM were observed in patients with AIH. (A) Representative immunohistochemistry images of ALCAM in liver biopsies from HC (n=3) and patients with AIH (n=6). (B) Representative immunofluorescence staining for CD4, CD6 and ALCAM in interface hepatitis lesion of liver sections from patients with AIH (n=3). (C) Concentration of serum ALCAM in HC (n=28) and AIH (n=86) was measured by ELISA assay. Individual correlation between clinical indicators and serum ALCAM was calculated in patients with AIH (n=86). (D) Correlation between the number of hepatic CD6 + cells and paired serum ALCAM concentration was calculated (n=27). ***p < 0.001.

Journal: Frontiers in Immunology

Article Title: Intrahepatic activated leukocyte cell adhesion molecule induces CD6 high CD4 + T cell infiltration in autoimmune hepatitis

doi: 10.3389/fimmu.2022.967944

Figure Lengend Snippet: Elevated hepatic and serum ALCAM were observed in patients with AIH. (A) Representative immunohistochemistry images of ALCAM in liver biopsies from HC (n=3) and patients with AIH (n=6). (B) Representative immunofluorescence staining for CD4, CD6 and ALCAM in interface hepatitis lesion of liver sections from patients with AIH (n=3). (C) Concentration of serum ALCAM in HC (n=28) and AIH (n=86) was measured by ELISA assay. Individual correlation between clinical indicators and serum ALCAM was calculated in patients with AIH (n=86). (D) Correlation between the number of hepatic CD6 + cells and paired serum ALCAM concentration was calculated (n=27). ***p < 0.001.

Article Snippet: Recombinant human ALCAM Fc chimera (R&D Systems, Minneapolis, MN, USA 7187-AL, referred as rhALCAM) was added when required.

Techniques: Immunohistochemistry, Immunofluorescence, Staining, Concentration Assay, Enzyme-linked Immunosorbent Assay

ALCAM promoted CD6 high CD4 + T cells trans-endothelial migration in vitro . (A, B) Human CD4 + T cells were magnetically isolated from PBMC of healthy donors and stimulated with αCD3/28 for 3 days in a flat-bottom 96-well plate, the expression of CD6 and cell proliferation was detected with flow cytometry. (C) After stimulation, the expression of cytokines, surface markers and transcription factors was compared between the CD6 high and CD6 low subsets. (D) Pre-activated CD4 + T cells were placed on a transwell chamber with 5μm pore for 24 hours in the presence of rhALCAM (3ug/ml) or vehicle (PBS). The expression of CD6 and CD69 was measured by flow cytometry. Experiments were repeated at least three times. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.

Journal: Frontiers in Immunology

Article Title: Intrahepatic activated leukocyte cell adhesion molecule induces CD6 high CD4 + T cell infiltration in autoimmune hepatitis

doi: 10.3389/fimmu.2022.967944

Figure Lengend Snippet: ALCAM promoted CD6 high CD4 + T cells trans-endothelial migration in vitro . (A, B) Human CD4 + T cells were magnetically isolated from PBMC of healthy donors and stimulated with αCD3/28 for 3 days in a flat-bottom 96-well plate, the expression of CD6 and cell proliferation was detected with flow cytometry. (C) After stimulation, the expression of cytokines, surface markers and transcription factors was compared between the CD6 high and CD6 low subsets. (D) Pre-activated CD4 + T cells were placed on a transwell chamber with 5μm pore for 24 hours in the presence of rhALCAM (3ug/ml) or vehicle (PBS). The expression of CD6 and CD69 was measured by flow cytometry. Experiments were repeated at least three times. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.

Article Snippet: Recombinant human ALCAM Fc chimera (R&D Systems, Minneapolis, MN, USA 7187-AL, referred as rhALCAM) was added when required.

Techniques: Migration, In Vitro, Isolation, Expressing, Flow Cytometry

Schematic diagram for this study. Upregulated ALCAM on hepatocytes promoted the trans-endothelial migration of pathogenic CD6 high CD4 + T cells, which further aggravated hepatic inflammation of patients with AIH. This study revealed a putative therapeutic approach for patients with AIH.

Journal: Frontiers in Immunology

Article Title: Intrahepatic activated leukocyte cell adhesion molecule induces CD6 high CD4 + T cell infiltration in autoimmune hepatitis

doi: 10.3389/fimmu.2022.967944

Figure Lengend Snippet: Schematic diagram for this study. Upregulated ALCAM on hepatocytes promoted the trans-endothelial migration of pathogenic CD6 high CD4 + T cells, which further aggravated hepatic inflammation of patients with AIH. This study revealed a putative therapeutic approach for patients with AIH.

Article Snippet: Recombinant human ALCAM Fc chimera (R&D Systems, Minneapolis, MN, USA 7187-AL, referred as rhALCAM) was added when required.

Techniques: Migration

Comparative analysis of MSC and Chondrocyte markers in the tissue (D0) isolated from mild and severe OA regions. ( A ) The mRNA expression levels of CD105, CD166 and Notch 1 (MSC markers) in mild versus severe OA at D0; ( B ) The mRNA expression levels of Sox9, Acan and Col II (chondrocyte markers) in mild versus severe OA at D0. Mild OA is used as the control expression to normalized results.

Journal: International Journal of Molecular Sciences

Article Title: Progenitor Cells from Cartilage: Grade Specific Differences in Stem Cell Marker Expression

doi: 10.3390/ijms18081759

Figure Lengend Snippet: Comparative analysis of MSC and Chondrocyte markers in the tissue (D0) isolated from mild and severe OA regions. ( A ) The mRNA expression levels of CD105, CD166 and Notch 1 (MSC markers) in mild versus severe OA at D0; ( B ) The mRNA expression levels of Sox9, Acan and Col II (chondrocyte markers) in mild versus severe OA at D0. Mild OA is used as the control expression to normalized results.

Article Snippet: Cells were expanded for 2 weeks in DMEM/F12 supplemented with FBS 10%, PS 1% and Fungizon 0.1% (GibcoTM, Courtaboeuf, France) and then subjected to immunofluorescence for antibodies to anti-goat Notch 1 (1:50; sc-9170, Santa Cruz Biotechecnology ® , Inc., Dallas, TX, USA), anti-rabbit CD90 (1:50; sc-9163, Santa Cruz Biotechecnology ® , Inc.), anti-mouse CD166 (1:50; sc-74557, Santa Cruz Biotechecnology ® , Inc., Santa Cruz, CA, USA), anti-rabbit nucleostemin (1:100; ab 70346, Abcam ® , Paris, France), anti-rabbit CD73 (1:50; ab175396, Abcam ® , Paris, France) and R-phycoerythrin-conjugated anti-CD105 (clone SN6; IgG1; Ancell Corporation, Bayport, MN, USA).

Techniques: Isolation, Expressing, Control

Comparative analysis of MSC and Chondrocyte markers between tissue (D0) and proliferated cells (D14) in Mild OA. ( A ) The mRNA expression levels of CD105, CD166 and Notch 1 (MSC markers) at D14 versus D0; ( B ) The mRNA expression levels of Sox9, Acan and Col II (chondrocytes markers) at D14 versus D0. D0 is used as the control expression to normalise results. ** p < 0.01, *** p < 0.001, **** p < 0.0001, Student’s t -test ( n = 8 in Mild OA, n = 6 in severe OA).

Journal: International Journal of Molecular Sciences

Article Title: Progenitor Cells from Cartilage: Grade Specific Differences in Stem Cell Marker Expression

doi: 10.3390/ijms18081759

Figure Lengend Snippet: Comparative analysis of MSC and Chondrocyte markers between tissue (D0) and proliferated cells (D14) in Mild OA. ( A ) The mRNA expression levels of CD105, CD166 and Notch 1 (MSC markers) at D14 versus D0; ( B ) The mRNA expression levels of Sox9, Acan and Col II (chondrocytes markers) at D14 versus D0. D0 is used as the control expression to normalise results. ** p < 0.01, *** p < 0.001, **** p < 0.0001, Student’s t -test ( n = 8 in Mild OA, n = 6 in severe OA).

Article Snippet: Cells were expanded for 2 weeks in DMEM/F12 supplemented with FBS 10%, PS 1% and Fungizon 0.1% (GibcoTM, Courtaboeuf, France) and then subjected to immunofluorescence for antibodies to anti-goat Notch 1 (1:50; sc-9170, Santa Cruz Biotechecnology ® , Inc., Dallas, TX, USA), anti-rabbit CD90 (1:50; sc-9163, Santa Cruz Biotechecnology ® , Inc.), anti-mouse CD166 (1:50; sc-74557, Santa Cruz Biotechecnology ® , Inc., Santa Cruz, CA, USA), anti-rabbit nucleostemin (1:100; ab 70346, Abcam ® , Paris, France), anti-rabbit CD73 (1:50; ab175396, Abcam ® , Paris, France) and R-phycoerythrin-conjugated anti-CD105 (clone SN6; IgG1; Ancell Corporation, Bayport, MN, USA).

Techniques: Expressing, Control

Comparative analysis of MSC and Chondrocytes markers between tissue (D0) and proliferated cells (D14) in severe OA. ( A ) The mRNA expression levels of CD105, CD166 and Notch 1 (MSC markers) at D14 versus D0; ( B ) The mRNA expression levels of Sox9, Acan and Col II (chondrocytes markers) at D14 versus D0. D0 is used as the control expression to normalized results. ** p < 0.01, Student’s t -test ( n = 8 in Mild OA, n = 6 in severe OA).

Journal: International Journal of Molecular Sciences

Article Title: Progenitor Cells from Cartilage: Grade Specific Differences in Stem Cell Marker Expression

doi: 10.3390/ijms18081759

Figure Lengend Snippet: Comparative analysis of MSC and Chondrocytes markers between tissue (D0) and proliferated cells (D14) in severe OA. ( A ) The mRNA expression levels of CD105, CD166 and Notch 1 (MSC markers) at D14 versus D0; ( B ) The mRNA expression levels of Sox9, Acan and Col II (chondrocytes markers) at D14 versus D0. D0 is used as the control expression to normalized results. ** p < 0.01, Student’s t -test ( n = 8 in Mild OA, n = 6 in severe OA).

Article Snippet: Cells were expanded for 2 weeks in DMEM/F12 supplemented with FBS 10%, PS 1% and Fungizon 0.1% (GibcoTM, Courtaboeuf, France) and then subjected to immunofluorescence for antibodies to anti-goat Notch 1 (1:50; sc-9170, Santa Cruz Biotechecnology ® , Inc., Dallas, TX, USA), anti-rabbit CD90 (1:50; sc-9163, Santa Cruz Biotechecnology ® , Inc.), anti-mouse CD166 (1:50; sc-74557, Santa Cruz Biotechecnology ® , Inc., Santa Cruz, CA, USA), anti-rabbit nucleostemin (1:100; ab 70346, Abcam ® , Paris, France), anti-rabbit CD73 (1:50; ab175396, Abcam ® , Paris, France) and R-phycoerythrin-conjugated anti-CD105 (clone SN6; IgG1; Ancell Corporation, Bayport, MN, USA).

Techniques: Expressing, Control

Protein expression of MSC markers in Mild and severe OA-derived cells at D14 (scale bar 20 µm). Immunofluorescence of Nucleostemin, CD105, CD166, CD73, CD90 and Notch 1 in proliferated cells (D14) isolated from areas of Mild OA ( A ) and severe OA ( B ). Markers of interest-RE staining (Red), contra staining DAPI (blue), and Isotype control + DAPI-left corner of each image.

Journal: International Journal of Molecular Sciences

Article Title: Progenitor Cells from Cartilage: Grade Specific Differences in Stem Cell Marker Expression

doi: 10.3390/ijms18081759

Figure Lengend Snippet: Protein expression of MSC markers in Mild and severe OA-derived cells at D14 (scale bar 20 µm). Immunofluorescence of Nucleostemin, CD105, CD166, CD73, CD90 and Notch 1 in proliferated cells (D14) isolated from areas of Mild OA ( A ) and severe OA ( B ). Markers of interest-RE staining (Red), contra staining DAPI (blue), and Isotype control + DAPI-left corner of each image.

Article Snippet: Cells were expanded for 2 weeks in DMEM/F12 supplemented with FBS 10%, PS 1% and Fungizon 0.1% (GibcoTM, Courtaboeuf, France) and then subjected to immunofluorescence for antibodies to anti-goat Notch 1 (1:50; sc-9170, Santa Cruz Biotechecnology ® , Inc., Dallas, TX, USA), anti-rabbit CD90 (1:50; sc-9163, Santa Cruz Biotechecnology ® , Inc.), anti-mouse CD166 (1:50; sc-74557, Santa Cruz Biotechecnology ® , Inc., Santa Cruz, CA, USA), anti-rabbit nucleostemin (1:100; ab 70346, Abcam ® , Paris, France), anti-rabbit CD73 (1:50; ab175396, Abcam ® , Paris, France) and R-phycoerythrin-conjugated anti-CD105 (clone SN6; IgG1; Ancell Corporation, Bayport, MN, USA).

Techniques: Expressing, Derivative Assay, Immunofluorescence, Isolation, Staining, Control

Comparative analysis of MSC and Chondrocyte markers in proliferated cells (D14) isolated from mild and severe OA regions. ( A ) The mRNA expression levels of CD105, CD166 and Notch 1 (MSC markers) in mild versus severe OA at D14; ( B ) The mRNA expression levels of Sox9, Acan and Col II (chondrocytes markers) in mild versus severe OA at D148. Mild OA is used as the control expression to normalized results. * p < 0.05, ** p < 0.01, Student’s t -test ( n = 8 in Mild OA, n = 6 in severe OA).

Journal: International Journal of Molecular Sciences

Article Title: Progenitor Cells from Cartilage: Grade Specific Differences in Stem Cell Marker Expression

doi: 10.3390/ijms18081759

Figure Lengend Snippet: Comparative analysis of MSC and Chondrocyte markers in proliferated cells (D14) isolated from mild and severe OA regions. ( A ) The mRNA expression levels of CD105, CD166 and Notch 1 (MSC markers) in mild versus severe OA at D14; ( B ) The mRNA expression levels of Sox9, Acan and Col II (chondrocytes markers) in mild versus severe OA at D148. Mild OA is used as the control expression to normalized results. * p < 0.05, ** p < 0.01, Student’s t -test ( n = 8 in Mild OA, n = 6 in severe OA).

Article Snippet: Cells were expanded for 2 weeks in DMEM/F12 supplemented with FBS 10%, PS 1% and Fungizon 0.1% (GibcoTM, Courtaboeuf, France) and then subjected to immunofluorescence for antibodies to anti-goat Notch 1 (1:50; sc-9170, Santa Cruz Biotechecnology ® , Inc., Dallas, TX, USA), anti-rabbit CD90 (1:50; sc-9163, Santa Cruz Biotechecnology ® , Inc.), anti-mouse CD166 (1:50; sc-74557, Santa Cruz Biotechecnology ® , Inc., Santa Cruz, CA, USA), anti-rabbit nucleostemin (1:100; ab 70346, Abcam ® , Paris, France), anti-rabbit CD73 (1:50; ab175396, Abcam ® , Paris, France) and R-phycoerythrin-conjugated anti-CD105 (clone SN6; IgG1; Ancell Corporation, Bayport, MN, USA).

Techniques: Isolation, Expressing, Control

( a ) Representative FACS profiles of stromal cells (CD45 − Ter119 − CD31 − ) near the endosteum (bone-disassociated). They were separated based on their CD166, CD146 and Sca1 expression profiles. Numbers shown in the gate represent the percentage of total live cells. ( b ) Single-cell colony forming efficiency of BM stromal progenitors (*: P ≤0.05, three repeats of 60 cells each, student's t -test). ( c ) Sections of femur from Flk1-GFP mouse stained with antibodies against Sca1 and scanned with an iCys Research imaging cytometer. Nuclei were stained with Dapi. ( d ) Confocal maximum intensity projections of sections of femurs from Flk1-GFP mice stained with antibodies against Sca1 or CD146; scanned near the epiphyseal plate. ( e ) Confocal maximum intensity projections of sections of femur stained with antibodies against Sca1 or CD146 and laminin; scanned near epiphyseal plate. White arrows point to mesenchymal progenitors yellow arrows point to endothelial cells.

Journal: Nature Communications

Article Title: Identification of a common mesenchymal stromal progenitor for the adult haematopoietic niche

doi: 10.1038/ncomms13095

Figure Lengend Snippet: ( a ) Representative FACS profiles of stromal cells (CD45 − Ter119 − CD31 − ) near the endosteum (bone-disassociated). They were separated based on their CD166, CD146 and Sca1 expression profiles. Numbers shown in the gate represent the percentage of total live cells. ( b ) Single-cell colony forming efficiency of BM stromal progenitors (*: P ≤0.05, three repeats of 60 cells each, student's t -test). ( c ) Sections of femur from Flk1-GFP mouse stained with antibodies against Sca1 and scanned with an iCys Research imaging cytometer. Nuclei were stained with Dapi. ( d ) Confocal maximum intensity projections of sections of femurs from Flk1-GFP mice stained with antibodies against Sca1 or CD146; scanned near the epiphyseal plate. ( e ) Confocal maximum intensity projections of sections of femur stained with antibodies against Sca1 or CD146 and laminin; scanned near epiphyseal plate. White arrows point to mesenchymal progenitors yellow arrows point to endothelial cells.

Article Snippet: Sections were blocked with 1% BSA, then probed with primary antibody at 4 °C overnight; purified rat-anti-Sca1 (1:50 BioLegend 108102), purified rat-anti-CD146 (1:50, BioLegend 134702), CD166-Fitc (1:25 R&D Systems FAB1172F), CD45-Alexa647 (1:50 BioLegend 103124) and/or rabbit-anti-laminin (1:200 Sigma-Aldrich L9393-.2ML).

Techniques: Expressing, Staining, Imaging, Cytometry

( a – b ) FACS analysis of bone-disassociated stromal cells (CD45 − TER119 − CD31 − ) from ( a ) Col2.3-GFP or ( b ) Osx1-Cre:GFP mice. The fequency of the parent gate is displayed. ( c – d ) The frequency of Sca1+, CD146+, CD166+ and Sca1- in the GFP+ population for (mean±s.d.) ( c ) Col2.3-GFP and ( d ) Osx1-Cre:GFP obtained from FACS analysis ( n =3). ( e – f ) Sections of femurs from ( e ) Col2.3-GFP or ( f ) Osx1-Cre:GFP mice stained with antidodies to Sca1 or CD146.

Journal: Nature Communications

Article Title: Identification of a common mesenchymal stromal progenitor for the adult haematopoietic niche

doi: 10.1038/ncomms13095

Figure Lengend Snippet: ( a – b ) FACS analysis of bone-disassociated stromal cells (CD45 − TER119 − CD31 − ) from ( a ) Col2.3-GFP or ( b ) Osx1-Cre:GFP mice. The fequency of the parent gate is displayed. ( c – d ) The frequency of Sca1+, CD146+, CD166+ and Sca1- in the GFP+ population for (mean±s.d.) ( c ) Col2.3-GFP and ( d ) Osx1-Cre:GFP obtained from FACS analysis ( n =3). ( e – f ) Sections of femurs from ( e ) Col2.3-GFP or ( f ) Osx1-Cre:GFP mice stained with antidodies to Sca1 or CD146.

Article Snippet: Sections were blocked with 1% BSA, then probed with primary antibody at 4 °C overnight; purified rat-anti-Sca1 (1:50 BioLegend 108102), purified rat-anti-CD146 (1:50, BioLegend 134702), CD166-Fitc (1:25 R&D Systems FAB1172F), CD45-Alexa647 (1:50 BioLegend 103124) and/or rabbit-anti-laminin (1:200 Sigma-Aldrich L9393-.2ML).

Techniques: Staining

( a ) Representative qRT-PCR of 18 single cells from CD146 + , CD166 + or Sca1 + stromal populations either near the endosteum (bone-disassociated) or in the marrow (Marrow) using the Fluidigm 48.48 dynamic array. Each column within a given population represents expression in an individual cell. ( b ) Comparison of the first and second prinicpal components from a principal component analysis of single-cell PCR gene expression data from all 47 genes. ( c – e ) Expression patterns of genes that are significantly overexpressed in mean±s.d. ( c ) Sca1 + cells ( d ) Sca1 + cells and/or CD146 + cells, or ( e ) CD166 + cells. Statistical significance was calculated using one-way ANOVA analysis * P ≤0.05, ** P ≤0.005, *** P ≤0.00; n =72. ANOVA, analysis of variance.

Journal: Nature Communications

Article Title: Identification of a common mesenchymal stromal progenitor for the adult haematopoietic niche

doi: 10.1038/ncomms13095

Figure Lengend Snippet: ( a ) Representative qRT-PCR of 18 single cells from CD146 + , CD166 + or Sca1 + stromal populations either near the endosteum (bone-disassociated) or in the marrow (Marrow) using the Fluidigm 48.48 dynamic array. Each column within a given population represents expression in an individual cell. ( b ) Comparison of the first and second prinicpal components from a principal component analysis of single-cell PCR gene expression data from all 47 genes. ( c – e ) Expression patterns of genes that are significantly overexpressed in mean±s.d. ( c ) Sca1 + cells ( d ) Sca1 + cells and/or CD146 + cells, or ( e ) CD166 + cells. Statistical significance was calculated using one-way ANOVA analysis * P ≤0.05, ** P ≤0.005, *** P ≤0.00; n =72. ANOVA, analysis of variance.

Article Snippet: Sections were blocked with 1% BSA, then probed with primary antibody at 4 °C overnight; purified rat-anti-Sca1 (1:50 BioLegend 108102), purified rat-anti-CD146 (1:50, BioLegend 134702), CD166-Fitc (1:25 R&D Systems FAB1172F), CD45-Alexa647 (1:50 BioLegend 103124) and/or rabbit-anti-laminin (1:200 Sigma-Aldrich L9393-.2ML).

Techniques: Quantitative RT-PCR, Expressing, Comparison, Gene Expression

( a ) Sca1 + progenitors were transduced with lentivirus as indicated and 1,000 sorted GFP + Sca1 + progenitors were co-transplanted with unmarked fetal skeletal progenitors under the kidney capsule. ( b ) Representative cross sections of the engrafted ectopic bone stained with H&E (right) or GFP (left) to identify the donor origin, harvested 1 month after transplant. ( c ) Representative FACS profiles of LSK frequencies that were pre-gated for live, CD45 + lineage − cells. ( d ) Cellularity of the ectopic niche marrow (* P <0.05, n =5, student's t -test). ( e ) Rescue of lethally irradiated mice with 2 × 10 5 marrow cells from engrafted ectopic niche generated with either mixed Sca1 + /shKITL progenitors (red) or with Sca1 + /Scrambled shRNA progenitors (yellow) or control bone marrow from host tibia (black) ( n =8). ( f ) The schematic summaries our findings such that Sca1+ cells are the most primative giving rise to CXCL12 producing stromal cells, CD146+ cells and CD166+ cells. CD146+ and CD166+ cells are osteo-progenitors. It is possible that CD146+ is an intermidiary cell fate between Sca1+ cells and CD166+ cells.

Journal: Nature Communications

Article Title: Identification of a common mesenchymal stromal progenitor for the adult haematopoietic niche

doi: 10.1038/ncomms13095

Figure Lengend Snippet: ( a ) Sca1 + progenitors were transduced with lentivirus as indicated and 1,000 sorted GFP + Sca1 + progenitors were co-transplanted with unmarked fetal skeletal progenitors under the kidney capsule. ( b ) Representative cross sections of the engrafted ectopic bone stained with H&E (right) or GFP (left) to identify the donor origin, harvested 1 month after transplant. ( c ) Representative FACS profiles of LSK frequencies that were pre-gated for live, CD45 + lineage − cells. ( d ) Cellularity of the ectopic niche marrow (* P <0.05, n =5, student's t -test). ( e ) Rescue of lethally irradiated mice with 2 × 10 5 marrow cells from engrafted ectopic niche generated with either mixed Sca1 + /shKITL progenitors (red) or with Sca1 + /Scrambled shRNA progenitors (yellow) or control bone marrow from host tibia (black) ( n =8). ( f ) The schematic summaries our findings such that Sca1+ cells are the most primative giving rise to CXCL12 producing stromal cells, CD146+ cells and CD166+ cells. CD146+ and CD166+ cells are osteo-progenitors. It is possible that CD146+ is an intermidiary cell fate between Sca1+ cells and CD166+ cells.

Article Snippet: Sections were blocked with 1% BSA, then probed with primary antibody at 4 °C overnight; purified rat-anti-Sca1 (1:50 BioLegend 108102), purified rat-anti-CD146 (1:50, BioLegend 134702), CD166-Fitc (1:25 R&D Systems FAB1172F), CD45-Alexa647 (1:50 BioLegend 103124) and/or rabbit-anti-laminin (1:200 Sigma-Aldrich L9393-.2ML).

Techniques: Transduction, Staining, Irradiation, Generated, shRNA, Control

Comparison of urine biomarkers among patients with SLE, LN, and healthy controls. (A) Urine level of ALCAM. (B) Urine level of HPX. (C) Urine level of PRDX6. Statistical analyses were conducted using the Mann–Whitney U test. SLE, systemic lupus erythematosus; LN, lupus nephritis; ALCAM, activated leukocyte cell adhesion molecule; HPX, hemopexin; PRDX, peroxiredoxin.

Journal: Frontiers in Immunology

Article Title: Longitudinal assessment of urinary ALCAM, HPX, and PRDX6 in Korean patients with systemic lupus erythematosus: implications for disease activity monitoring and treatment response

doi: 10.3389/fimmu.2024.1369385

Figure Lengend Snippet: Comparison of urine biomarkers among patients with SLE, LN, and healthy controls. (A) Urine level of ALCAM. (B) Urine level of HPX. (C) Urine level of PRDX6. Statistical analyses were conducted using the Mann–Whitney U test. SLE, systemic lupus erythematosus; LN, lupus nephritis; ALCAM, activated leukocyte cell adhesion molecule; HPX, hemopexin; PRDX, peroxiredoxin.

Article Snippet: The concentration of biomarker levels in mouse urine was analyzed using enzyme-linked immunosorbent assay (ELISA) kits specific for ALCAM (Catalog # DY656; R&D Systems, Minneapolis, MN, USA), HPX (Catalog # ab108860; Abcam Inc, Toronto, ON, Canada) and PRDX 6 (Catalog # MBS067069; Mybiosource, San Diego, CA, USA), according to the manufacturer’s protocols.

Techniques: Comparison, MANN-WHITNEY

ROC curves for urine ALCAM, HPX, and PRDX in the diagnosis of SLE and LN compared to healthy controls. (A) For SLE (non-renal + renal) diagnosis, the AUC was 0.801 for the urine ALCAM (95% CI, 0.734 – 0.868), 0.707 for the urine hemopexin (95% CI, 0.622 – 0.792), and 0.697 for the urine PRDX (95% CI, 0.612 – 0.782). (B) For LN diagnosis, the AUC was 0.850 for the urine ALCAM (95% CI, 0.778 – 0.921), 0.781 for the urine hemopexin (95% CI, 0.695 – 0.867), and 0.714 for the urine PRDX (95% CI, 0.617 – 0.812). ROC, Receiver operating characteristic; SLE, systemic lupus erythematosus; LN, lupus nephritis; ALCAM, activated leukocyte cell adhesion molecule; HPX, hemopexin; PRDX, peroxiredoxin; AUC, area under the receiver operating characteristic curve; CI, confidence interval.

Journal: Frontiers in Immunology

Article Title: Longitudinal assessment of urinary ALCAM, HPX, and PRDX6 in Korean patients with systemic lupus erythematosus: implications for disease activity monitoring and treatment response

doi: 10.3389/fimmu.2024.1369385

Figure Lengend Snippet: ROC curves for urine ALCAM, HPX, and PRDX in the diagnosis of SLE and LN compared to healthy controls. (A) For SLE (non-renal + renal) diagnosis, the AUC was 0.801 for the urine ALCAM (95% CI, 0.734 – 0.868), 0.707 for the urine hemopexin (95% CI, 0.622 – 0.792), and 0.697 for the urine PRDX (95% CI, 0.612 – 0.782). (B) For LN diagnosis, the AUC was 0.850 for the urine ALCAM (95% CI, 0.778 – 0.921), 0.781 for the urine hemopexin (95% CI, 0.695 – 0.867), and 0.714 for the urine PRDX (95% CI, 0.617 – 0.812). ROC, Receiver operating characteristic; SLE, systemic lupus erythematosus; LN, lupus nephritis; ALCAM, activated leukocyte cell adhesion molecule; HPX, hemopexin; PRDX, peroxiredoxin; AUC, area under the receiver operating characteristic curve; CI, confidence interval.

Article Snippet: The concentration of biomarker levels in mouse urine was analyzed using enzyme-linked immunosorbent assay (ELISA) kits specific for ALCAM (Catalog # DY656; R&D Systems, Minneapolis, MN, USA), HPX (Catalog # ab108860; Abcam Inc, Toronto, ON, Canada) and PRDX 6 (Catalog # MBS067069; Mybiosource, San Diego, CA, USA), according to the manufacturer’s protocols.

Techniques: Biomarker Discovery

Correlation between urine biomarkers and disease activity markers in patients with SLE.

Journal: Frontiers in Immunology

Article Title: Longitudinal assessment of urinary ALCAM, HPX, and PRDX6 in Korean patients with systemic lupus erythematosus: implications for disease activity monitoring and treatment response

doi: 10.3389/fimmu.2024.1369385

Figure Lengend Snippet: Correlation between urine biomarkers and disease activity markers in patients with SLE.

Article Snippet: The concentration of biomarker levels in mouse urine was analyzed using enzyme-linked immunosorbent assay (ELISA) kits specific for ALCAM (Catalog # DY656; R&D Systems, Minneapolis, MN, USA), HPX (Catalog # ab108860; Abcam Inc, Toronto, ON, Canada) and PRDX 6 (Catalog # MBS067069; Mybiosource, San Diego, CA, USA), according to the manufacturer’s protocols.

Techniques: Activity Assay

Comparison of  ALCAM,   HPX,  and PRDX according to clinical manifestations in patients with SLE.

Journal: Frontiers in Immunology

Article Title: Longitudinal assessment of urinary ALCAM, HPX, and PRDX6 in Korean patients with systemic lupus erythematosus: implications for disease activity monitoring and treatment response

doi: 10.3389/fimmu.2024.1369385

Figure Lengend Snippet: Comparison of ALCAM, HPX, and PRDX according to clinical manifestations in patients with SLE.

Article Snippet: The concentration of biomarker levels in mouse urine was analyzed using enzyme-linked immunosorbent assay (ELISA) kits specific for ALCAM (Catalog # DY656; R&D Systems, Minneapolis, MN, USA), HPX (Catalog # ab108860; Abcam Inc, Toronto, ON, Canada) and PRDX 6 (Catalog # MBS067069; Mybiosource, San Diego, CA, USA), according to the manufacturer’s protocols.

Techniques: Comparison

Changes in urine biomarker levels in follow-up observations of patients with SLE without LN and patients with LN. (A) Urine level of ALCAM. (B) Urine level of HPX. (C) Urine level of PRDX6. Statistical analyses were conducted using the Mann–Whitney U test. SLE, systemic lupus erythematosus; LN, lupus nephritis; ALCAM, activated leukocyte cell adhesion molecule; HPX, hemopexin; PRDX, peroxiredoxin.

Journal: Frontiers in Immunology

Article Title: Longitudinal assessment of urinary ALCAM, HPX, and PRDX6 in Korean patients with systemic lupus erythematosus: implications for disease activity monitoring and treatment response

doi: 10.3389/fimmu.2024.1369385

Figure Lengend Snippet: Changes in urine biomarker levels in follow-up observations of patients with SLE without LN and patients with LN. (A) Urine level of ALCAM. (B) Urine level of HPX. (C) Urine level of PRDX6. Statistical analyses were conducted using the Mann–Whitney U test. SLE, systemic lupus erythematosus; LN, lupus nephritis; ALCAM, activated leukocyte cell adhesion molecule; HPX, hemopexin; PRDX, peroxiredoxin.

Article Snippet: The concentration of biomarker levels in mouse urine was analyzed using enzyme-linked immunosorbent assay (ELISA) kits specific for ALCAM (Catalog # DY656; R&D Systems, Minneapolis, MN, USA), HPX (Catalog # ab108860; Abcam Inc, Toronto, ON, Canada) and PRDX 6 (Catalog # MBS067069; Mybiosource, San Diego, CA, USA), according to the manufacturer’s protocols.

Techniques: Biomarker Discovery, MANN-WHITNEY

Changes in urine biomarker Levels of patients with SLE without LN and patients with LN only follow-up. (A) Urine level of ALCAM. (B) Urine level of HPX. (C) Urine level of PRDX6. Statistical analyses were conducted using the Mann–Whitney U test. SLE, systemic lupus erythematosus; LN, lupus nephritis; ALCAM, activated leukocyte cell adhesion molecule; HPX, hemopexin; PRDX, peroxiredoxin.

Journal: Frontiers in Immunology

Article Title: Longitudinal assessment of urinary ALCAM, HPX, and PRDX6 in Korean patients with systemic lupus erythematosus: implications for disease activity monitoring and treatment response

doi: 10.3389/fimmu.2024.1369385

Figure Lengend Snippet: Changes in urine biomarker Levels of patients with SLE without LN and patients with LN only follow-up. (A) Urine level of ALCAM. (B) Urine level of HPX. (C) Urine level of PRDX6. Statistical analyses were conducted using the Mann–Whitney U test. SLE, systemic lupus erythematosus; LN, lupus nephritis; ALCAM, activated leukocyte cell adhesion molecule; HPX, hemopexin; PRDX, peroxiredoxin.

Article Snippet: The concentration of biomarker levels in mouse urine was analyzed using enzyme-linked immunosorbent assay (ELISA) kits specific for ALCAM (Catalog # DY656; R&D Systems, Minneapolis, MN, USA), HPX (Catalog # ab108860; Abcam Inc, Toronto, ON, Canada) and PRDX 6 (Catalog # MBS067069; Mybiosource, San Diego, CA, USA), according to the manufacturer’s protocols.

Techniques: Biomarker Discovery, MANN-WHITNEY

Association between changes in biomarker levels and disease activity during follow-up examinations. (A) Correlation between ΔALCAM and ΔSLEDAI-2k. (B) Correlation between HPX and SLEDAI-2k. (C) Correlation between Δ PRDX6 and ΔSLEDAI-2k. SLEDAI, SLE disease activity index 2000; ALCAM, activated leukocyte cell adhesion molecule; HPX, hemopexin; PRDX, peroxiredoxin.

Journal: Frontiers in Immunology

Article Title: Longitudinal assessment of urinary ALCAM, HPX, and PRDX6 in Korean patients with systemic lupus erythematosus: implications for disease activity monitoring and treatment response

doi: 10.3389/fimmu.2024.1369385

Figure Lengend Snippet: Association between changes in biomarker levels and disease activity during follow-up examinations. (A) Correlation between ΔALCAM and ΔSLEDAI-2k. (B) Correlation between HPX and SLEDAI-2k. (C) Correlation between Δ PRDX6 and ΔSLEDAI-2k. SLEDAI, SLE disease activity index 2000; ALCAM, activated leukocyte cell adhesion molecule; HPX, hemopexin; PRDX, peroxiredoxin.

Article Snippet: The concentration of biomarker levels in mouse urine was analyzed using enzyme-linked immunosorbent assay (ELISA) kits specific for ALCAM (Catalog # DY656; R&D Systems, Minneapolis, MN, USA), HPX (Catalog # ab108860; Abcam Inc, Toronto, ON, Canada) and PRDX 6 (Catalog # MBS067069; Mybiosource, San Diego, CA, USA), according to the manufacturer’s protocols.

Techniques: Biomarker Discovery, Activity Assay

Coronal cryostat sections of the hindbrain of E11 and E13 embryos and spinal cord (brachial level) of E11 embryos . a-b , In Foxg1:Cre;Netrin-1 L/+ embryos as in wild type, netrin-1 is in the hindbrain VZ (arrowhead) and commissural axons (arrow). This is not the case in Foxg1:Cre;Netrin-1 L/L mutant. The floor plate is still labelled (Fp). Note that netrin-1 is present in the vicinity of the Fp (n=6). c , Foxg1:Cre drives Cre expression in E13 (left) and E11 (right) hindbrain cells (Tomato+ cells in red) but not in the floor plate (arrowheads; n=3/3). A few Alcam+ floor plate cells are Tomato+. d, e, Netrin-1 distribution is similar in the spinal cord of Foxg1:Cre;Netrin-1 L/+ (d) and Foxg1:Cre;Netrin-1 L/L ( e ) embryos (n=5). f , In Netrin1 ßgeo/ßgeo , Foxp2+ olivary neurons fail to migrate (arrowheads) ventrally and only few of them are able to reach to the floor plate (arrowheads; n=6). g , Quantification of the size of hindbrain commissures in the different mutants compared to controls. Six embryos of each genotype and 9 sections from each were quantified. Data are normalized with the wt and are represented as the mean ± SEM (One-way Kruskal-Wallis with Mann-Whitney post-test, *P<0.05, ns, not significant). h, Netrin-1 guidance mechanisms of hindbrain commissural axons: past and current models. In the initial model, soluble netrin-1 secreted by floor plate (FP) forms a ventro-dorsal gradient, which attracts ventrally commissural axon (CN) growth cones (GC). In the revised model, pioneer CN axons form in a superficial region containing high levels of netrin-1 produced by neural progenitor cells (NPCs) extending from the ventricular zone (VZ) to the basal lamina (BL) at the surface of the hindbrain. CN axons might also capture Netrin-1 and establish a netrin-1-rich pathway guiding follower axons. Their ventral extension might be facilitated by chemorepellents (question mark) produced in the dorsal hindbrain. Scale bars, 100µm.

Journal: Nature

Article Title: Floor plate-derived netrin-1 is dispensable for commissural axon guidance

doi: 10.1038/nature22331

Figure Lengend Snippet: Coronal cryostat sections of the hindbrain of E11 and E13 embryos and spinal cord (brachial level) of E11 embryos . a-b , In Foxg1:Cre;Netrin-1 L/+ embryos as in wild type, netrin-1 is in the hindbrain VZ (arrowhead) and commissural axons (arrow). This is not the case in Foxg1:Cre;Netrin-1 L/L mutant. The floor plate is still labelled (Fp). Note that netrin-1 is present in the vicinity of the Fp (n=6). c , Foxg1:Cre drives Cre expression in E13 (left) and E11 (right) hindbrain cells (Tomato+ cells in red) but not in the floor plate (arrowheads; n=3/3). A few Alcam+ floor plate cells are Tomato+. d, e, Netrin-1 distribution is similar in the spinal cord of Foxg1:Cre;Netrin-1 L/+ (d) and Foxg1:Cre;Netrin-1 L/L ( e ) embryos (n=5). f , In Netrin1 ßgeo/ßgeo , Foxp2+ olivary neurons fail to migrate (arrowheads) ventrally and only few of them are able to reach to the floor plate (arrowheads; n=6). g , Quantification of the size of hindbrain commissures in the different mutants compared to controls. Six embryos of each genotype and 9 sections from each were quantified. Data are normalized with the wt and are represented as the mean ± SEM (One-way Kruskal-Wallis with Mann-Whitney post-test, *P<0.05, ns, not significant). h, Netrin-1 guidance mechanisms of hindbrain commissural axons: past and current models. In the initial model, soluble netrin-1 secreted by floor plate (FP) forms a ventro-dorsal gradient, which attracts ventrally commissural axon (CN) growth cones (GC). In the revised model, pioneer CN axons form in a superficial region containing high levels of netrin-1 produced by neural progenitor cells (NPCs) extending from the ventricular zone (VZ) to the basal lamina (BL) at the surface of the hindbrain. CN axons might also capture Netrin-1 and establish a netrin-1-rich pathway guiding follower axons. Their ventral extension might be facilitated by chemorepellents (question mark) produced in the dorsal hindbrain. Scale bars, 100µm.

Article Snippet: Sections were then incubated O/N with the following primary antibodies: goat anti-human Robo3 (1:250, R&D Systems AF3076), goat anti-Dcc (1:500, Santa Cruz sc-6535), goat anti-Robo1 (1:500, R&D Systems AF1749), rat anti-mouse Netrin-1 (1:500, R&D Systems MAB1109), mouse anti-Nestin-Alexa488 (1:1000, Abcam ab197495), mouse anti Neurofilament (1:300, DSHB 2H3), goat anti-Foxp2 (1:1000, Santa Cruz sc-21069), rabbit anti-Foxp2 (1:1000, Abcam AB16046), rabbit anti-Sox2 (1:500, Abcam ab97959), rabbit anti-βgal (1:500, Cappel 55976), goat anti-human Alcam (1:500, R&D Systems AF656), rabbit anti-GFP (1:800, Life Technologies A11122), rabbit anti-Dsred (1:500, Clontech 632496) followed by 2 hours incubation in species-specific secondary antibodies directly conjugated to fluorophores (Cy-5, Cy-3, Alexa-Fluor 647 from Jackson ImmunoResearch, or from Invitrogen).

Techniques: Mutagenesis, Expressing, MANN-WHITNEY, Produced